Market research
RMTI Rockwell Medical Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 33M
- P/E ratio
- Not available
- Analyst target
- 20
- Dividend yield
- Not available
- Beta
- 1.62
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- US7743744093
- Market cap
- 33M
- P/E ratio
- Not available
- Analyst target
- 20
- Dividend yield
- Not available
- Beta
- 1.62
About
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the RMTI discussion.
5 years, 4 months ago
Rockwell Medical, Inc is currently in a long term downtrend where the price is trading 22.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Rockwell Medical, Inc's total revenue sank by 2.1% to $15M since the same quarter in the previous year.
Its net income has dropped by 18.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow fell by 58.9% to $-9M since the same quarter in the previous year.
Based on the above factors, Rockwell Medical, Inc gets an overall score of 1/5.